,trastuzumab deruxtecan
roche,astrazeneca,daiichi sankyo
['trastuzumab,(-trastuzumab deruxtecan),(-trastuzumab-deruxtecan)', 'trastuzumab', 'in person']
#tdxd is here to change destinies!! incredibly grateful and proud of (also being associated with) this molecule and this institute albeit for a bit!! i seriously wish i could attend #asco2022 only for this in person &amp; of course asco 2005 for the adjuvant trastuzumab data! 
Medical Oncologist | Ambivert | Feminist| Centrist| ObsessivePetMom | CompulsiveTraveller |Occasional Reader| Potterhead |CoffeeAddict| Tidsoptimist Coddiwomple